Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Tesoro Corporation (NYSE:TSO) added 1.72% and is trading at $57.21. Tesoro Corporation (Tesoro) is an independent petroleum refiners and marketers in the United States. The Company’s subsidiaries, operating through two business segments: manufacture and sell transportation fuels. Its refining operating segment (refining), which operates seven refineries in the western United States, refines crude oil and other feedstocks into transportation fuels, such as gasoline, gasoline blendstocks, jet fuel and diesel fuel, as well as other products, including heavy fuel oils, liquefied petroleum gas, petroleum coke and asphalt.
How Should Investors Trade TSO After The Recent Movement? Find Out Here
InvenSense Inc (NYSE:INVN) is lower 4.99% and is trading at $11.42. InvenSense, Inc. designs and fabricates micro-electro-mechanical systems (MEMS) technologies. Its solution is comprised of an integrated circuit (IC) that incorporates motions sensors such as gyroscopes with associated software. The Company provide solutions to electronics applications such as console and portable video gaming devices, handset and tablet devices, digital still and video cameras, digital television and set-top box remote controls, 3D mice and portable navigation devices.
Is INVN Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here
Medivation, Inc. (NASDAQ:MDVN) fell down 6.43% and is trading at $45.98. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options. Together with its collaboration partner Astellas Pharma Inc. (Astellas), the Company is developing MDV3100 for multiple stages of advanced prostate cancer.
Is MDVN a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here
VIVUS, Inc. (NASDAQ:VVUS) is lower 4.48% and is trading at $10.23. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic drugs for underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes, and men's sexual health.
How Should Investors Trade VVUS After The Latest Earnings Report? Find Out Here
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)